Article
ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer.
Internal medicine (Tokyo, Japan) - 1 Jan 2020
Tanaka Yoshinori, Kumagi Teru, Terao Takashi, Kuroda Taira, Yokota Tomoyuki, Azemoto Nobuaki, Imamura Yoshiki, Uesugi Kazuhiro, Kisaka Yoshiyasu, Shibata Naozumi, Koizumi Mitsuhito, Ohno Yoshinori, Kanemitsu Kozue, Yukimoto Atsushi, Tange Kazuhiro, Nishiyama Mari, Miyake Teruki, Miyata Hideki, Ishii Hiroshi, Abe Masanori, Hiasa Yoichi
Abstract excerpt
Objective The long-term effect of the ABO blood type on the clinical course of patients with pancreatic cancer (PC) is inconclusive. This study aimed to determine whether or not the ABO blood type influences the long-term outcomes of PC in Japanese patients. Methods The medical records of Japanese patients with PC were reviewed. Data, including the age, sex, and outcomes, from the Ehime Pancreato-Cholangiology...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.